Suppliers / Abon Pharmaceuticals

Abon Pharmaceuticals

United States 61 employees Updated 9 July 2026

Abon Pharmaceuticals is a finished-dose manufacturer based in United States. It appears in 1 regulatory filing across 1 regulator, without an active US DMF or CEP on file. Its GMP standing is certified by US FDA. Its most recent recorded inspection, by US FDA, closed on 6 August 2025 as NAI.

0
active US DMFs
0
valid CEPs
1
registered plants 1 with an FDA FEI number
1
filings across 1 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 6 August 2025 NAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Chestnut Ridge, United States 3007923338

Filings and GMP by regulator

Regulator Filings GMP certificates
US FDA 1 1

Questions about Abon Pharmaceuticals

Does Abon Pharmaceuticals hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for Abon Pharmaceuticals. It does have 1 filing with one regulator, so it is registered, just not with the two strong registers buyers usually screen on.
Is Abon Pharmaceuticals FDA-registered?
One site operated by Abon Pharmaceuticals carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Abon Pharmaceuticals's last inspection go?
The most recent inspection on record closed on 6 August 2025 as NAI (No Action Indicated: nothing objectionable was found). 1 inspection is on file.
Where does Abon Pharmaceuticals manufacture?
1 registered site is on record, in United States (Chestnut Ridge). Every site is listed on this page with the register it came from.
Which regulators recognise Abon Pharmaceuticals's GMP?
Current GMP certificates are on record from US FDA. GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Abon Pharmaceuticals comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was NAI, on 6 August 2025.

Comparable suppliers

Aaa Pharmaceuticals also in United States Aarkish Pharmaceuticals NJ also in United States Abbott Laboratories also in United States Access Business Group also in United States Advance Pharmaceutical also in United States

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates